Milestone Scientific Achieves Revenue of $2.2 Million for the Third Quarter of 2022
ROSELAND, N.J., Nov. 15, 2022 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the third quarter ended September 30, 2022.
Related news for (MLSS)
- Milestone Scientific Appoints Jason Papes as Senior Vice President, Global Head of Sales and Marketing
- MoBot’s Stock Market Highlights – 08/04/25 12:00 PM
- Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
- Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
- Milestone Scientific Expands CompuFlo® Epidural System Footprint with InfiniSurg, LLC in New Jersey